Dissecting central post-stroke pain: a controlled symptom-psychophysical characterization

Carregando...
Imagem de Miniatura
Citações na Scopus
9
Tipo de produção
article
Data de publicação
2022
Título da Revista
ISSN da Revista
Título do Volume
Editora
OXFORD UNIV PRESS
Citação
BRAIN COMMUNICATIONS, v.4, n.3, article ID fcac090, 16p, 2022
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Dissection of distinct post-stroke pain syndromes evidenced that the neuropathic pain inventory, the presence of cold thermal deficit and the finding of allodynia on bedside examination, explained 77% of the occurrence of neuropathic central post-stroke pain, a new finding that has clear diagnostic potential. Central post-stroke pain affects up to 12% of stroke survivors and is notoriously refractory to treatment. However, stroke patients often suffer from other types of pain of non-neuropathic nature (musculoskeletal, inflammatory, complex regional) and no head-to-head comparison of their respective clinical and somatosensory profiles has been performed so far. We compared 39 patients with definite central neuropathic post-stroke pain with two matched control groups: 32 patients with exclusively non-neuropathic pain developed after stroke and 31 stroke patients not complaining of pain. Patients underwent deep phenotyping via a comprehensive assessment including clinical exam, questionnaires and quantitative sensory testing to dissect central post-stroke pain from chronic pain in general and stroke. While central post-stroke pain was mostly located in the face and limbs, non-neuropathic pain was predominantly axial and located in neck, shoulders and knees (P < 0.05). Neuropathic Pain Symptom Inventory clusters burning (82.1%, n = 32, P < 0.001), tingling (66.7%, n = 26, P < 0.001) and evoked by cold (64.1%, n = 25, P < 0.001) occurred more frequently in central post-stroke pain. Hyperpathia, thermal and mechanical allodynia also occurred more commonly in this group (P < 0.001), which also presented higher levels of deafferentation (P < 0.012) with more asymmetric cold and warm detection thresholds compared with controls. In particular, cold hypoesthesia (considered when the threshold of the affected side was <41% of the contralateral threshold) odds ratio (OR) was 12 (95% CI: 3.8-41.6) for neuropathic pain. Additionally, cold detection threshold/warm detection threshold ratio correlated with the presence of neuropathic pain (rho = -0.4, P < 0.001). Correlations were found between specific neuropathic pain symptom clusters and quantitative sensory testing: paroxysmal pain with cold (rho = -0.4; P = 0.008) and heat pain thresholds (rho = 0.5; P = 0.003), burning pain with mechanical detection (rho = -0.4; P = 0.015) and mechanical pain thresholds (rho = -0.4, P < 0.013), evoked pain with mechanical pain threshold (rho = -0.3; P = 0.047). Logistic regression showed that the combination of cold hypoesthesia on quantitative sensory testing, the Neuropathic Pain Symptom Inventory, and the allodynia intensity on bedside examination explained 77% of the occurrence of neuropathic pain. These findings provide insights into the clinical-psychophysics relationships in central post-stroke pain and may assist more precise distinction of neuropathic from non-neuropathic post-stroke pain in clinical practice and in future trials.
Palavras-chave
central post-stroke pain, post-stroke pain, neuropathic pain phenotyping, central neuropathic pain, quantitative sensory testing
Referências
  1. ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35
  2. Aparecida da Silva V., 2018, Neurophysiol Clin, V48, P287
  3. Attal N, 2008, PAIN, V138, P343, DOI 10.1016/j.pain.2008.01.006
  4. Attal N, 2002, NEUROLOGY, V58, P554, DOI 10.1212/WNL.58.4.554
  5. de Oliveira RAA, 2020, ARQ NEURO-PSIQUIAT, V78, P741, DOI [10.1590/0004-282X20200166, 10.1590/0004-282x20200166]
  6. de Oliveira RAA, 2014, J PAIN, V15, P1271, DOI 10.1016/j.jpain.2014.09.009
  7. de Oliveira RAA, 2012, BMC NEUROL, V12, DOI 10.1186/1471-2377-12-89
  8. Baptista AF., 2019, PAIN REP, V4, P1
  9. Baron R, 2017, PAIN, V158, P261, DOI 10.1097/j.pain.0000000000000753
  10. Bender R, 2001, J CLIN EPIDEMIOL, V54, P343, DOI 10.1016/S0895-4356(00)00314-0
  11. BERIC A, 1988, PAIN, V34, P109, DOI 10.1016/0304-3959(88)90155-8
  12. HOLMGREN H, 1990, PAIN, V40, P43, DOI 10.1016/0304-3959(90)91049-O
  13. Hosomi K, 2013, PAIN, V154, P1352, DOI 10.1016/j.pain.2013.04.017
  14. Indredavik B, 2008, STROKE, V39, P414, DOI 10.1161/STROKEAHA.107.489294
  15. JENSEN TS, 1991, ACTA NEUROL SCAND, V84, P326, DOI 10.1111/j.1600-0404.1991.tb04963.x
  16. Kadono Y, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-85409-w
  17. Kalita J, 2011, PAIN MED, V12, P282, DOI 10.1111/j.1526-4637.2010.01046.x
  18. KATZ RT, 1992, ARCH PHYS MED REHAB, V73, P339, DOI 10.1016/0003-9993(92)90007-J
  19. Kern D, 2008, PAIN, V135, P291, DOI 10.1016/j.pain.2007.12.001
  20. Klit H, 2014, PAIN, V155, P2699, DOI 10.1016/j.pain.2014.09.037
  21. Klit H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027607
  22. MacGowan DJL, 1997, NEUROLOGY, V49, P120, DOI 10.1212/WNL.49.1.120
  23. Klit H, 2011, PAIN, V152, P818, DOI 10.1016/j.pain.2010.12.030
  24. Klit H, 2009, LANCET NEUROL, V8, P857, DOI 10.1016/S1474-4422(09)70176-0
  25. Kong KH, 2004, ARCH PHYS MED REHAB, V85, P35, DOI 10.1016/S0003-9993(03)00369-1
  26. Krause T, 2016, PAIN, V157, P194, DOI 10.1097/j.pain.0000000000000354
  27. Kuptniratsaikul V, 2009, AM J PHYS MED REHAB, V88, P92, DOI 10.1097/PHM.0b013e3181909d5f
  28. Lefaucheur JP, 2006, NEUROLOGY, V67, P1568, DOI 10.1212/01.wnl.0000242731.10074.3c
  29. LEIJON G, 1989, PAIN, V36, P13, DOI 10.1016/0304-3959(89)90107-3
  30. Leijon G., 1990, PAIN, V41, pS468
  31. Lemos MD, 2022, PAIN, V163, P765, DOI 10.1097/j.pain.0000000000002427
  32. Leone C, 2019, PAIN, V160, P1967, DOI 10.1097/j.pain.0000000000001584
  33. MAHONEY F I, 1965, Md State Med J, V14, P61
  34. Li Q, 2015, NEUROIMAGE-CLIN, V8, P526, DOI 10.1016/j.nicl.2014.08.017
  35. Lopes LCG, 2018, EUR J PAIN, V22, P72, DOI 10.1002/ejp.1091
  36. MELZACK R, 1987, PAIN, V30, P191, DOI 10.1016/0304-3959(87)91074-8
  37. Moisset X, 2020, REV NEUROL-FRANCE, V176, P325, DOI 10.1016/j.neurol.2020.01.361
  38. Giordano PCM, 2012, REV LAT-AM ENFERM, V20, P76, DOI 10.1590/S0104-11692012000100011
  39. Nagasaka K, 2020, EXP NEUROL, V323, DOI 10.1016/j.expneurol.2019.113096
  40. Okifuji A, 1997, J RHEUMATOL, V24, P377
  41. Osterberg A, 2010, EUR J PAIN, V14, P104, DOI 10.1016/j.ejpain.2009.03.003
  42. Otto M, 2003, PAIN, V101, P187, DOI 10.1016/S0304-3959(02)00313-5
  43. Pai MYB, 2021, PAIN REP, V6, DOI 10.1097/PR9.0000000000000939
  44. Tang SC, 2019, STROKE, V50, P2851, DOI 10.1161/STROKEAHA.119.025692
  45. Pedler Ashley, 2010, J Physiother, V56, P137, DOI 10.1016/S1836-9553(10)70047-3
  46. Raicher I, 2018, PAIN REP, V3, DOI 10.1097/PR9.0000000000000638
  47. RANKIN J, 1957, Scott Med J, V2, P200
  48. Reimer M, 2020, PAIN REP, V5, DOI 10.1097/PR9.0000000000000820
  49. Rolke R, 2006, PAIN, V123, P231, DOI 10.1016/j.pain.2006.01.041
  50. Santos JG, 2010, J PAIN, V11, P484, DOI 10.1016/j.jpain.2009.09.014
  51. Ferreira KAS, 2013, PAIN MANAG NURS, V14, P210, DOI 10.1016/j.pmn.2011.04.006
  52. Simons DG., 1998, TRAVELL SIMONS SIMON, V2nd
  53. Sinay VJ, 2003, CEPHALALGIA, V23, P541, DOI 10.1046/j.1468-2982.2003.00581.x
  54. Sommer C, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-104
  55. Treede RD, 2008, NEUROLOGY, V70, P1630, DOI 10.1212/01.wnl.0000282763.29778.59
  56. Svendsen KB, 2005, PAIN, V114, P473, DOI 10.1016/j.pain.2005.01.015
  57. Takami K, 2011, J PHARM PHARMACOL, V63, P452, DOI 10.1111/j.2042-7158.2010.01231.x
  58. Truini A, 2009, PAIN, V145, P105, DOI 10.1016/j.pain.2009.05.023
  59. Truini A, 2016, PAIN, V157, pS53, DOI 10.1097/j.pain.0000000000000367
  60. Truini A, 2012, PAIN, V153, P2048, DOI 10.1016/j.pain.2012.05.024
  61. Urban PP, 2010, STROKE, V41, P2016, DOI 10.1161/STROKEAHA.110.581991
  62. Valerio F, 2020, EUR J PAIN, V24, P1548, DOI 10.1002/ejp.1608
  63. Vartiainen N, 2016, BRAIN, V139, P708, DOI 10.1093/brain/awv389
  64. VESTERGAARD K, 1995, PAIN, V61, P177, DOI 10.1016/0304-3959(94)00140-A
  65. Vollert J, 2017, PAIN, V158, P1446, DOI 10.1097/j.pain.0000000000000935
  66. Beric A, 1998, NEUROL CLIN, V16, P899, DOI 10.1016/S0733-8619(05)70104-3
  67. Vollert J, 2016, PAIN, V157, P1810, DOI 10.1097/j.pain.0000000000000588
  68. Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003
  69. Widar M, 2002, J REHABIL MED, V34, P165, DOI 10.1080/16501970213237
  70. Widar M, 2002, SCAND J CARING SCI, V16, P302, DOI 10.1046/j.1471-6712.2002.00090.x
  71. Widerstrom-Noga E, 2016, J NEUROTRAUM, V33, P482, DOI 10.1089/neu.2015.4040
  72. Wissel J, 2010, J NEUROL, V257, P1067, DOI 10.1007/s00415-010-5463-1
  73. Yamamoto T, 1997, PAIN, V72, P5, DOI 10.1016/S0304-3959(97)00028-6
  74. Yang F, 2014, NEUROSCI BULL, V30, P887, DOI 10.1007/s12264-014-1477-5
  75. Zeilig G, 2012, BRAIN, V135, P418, DOI 10.1093/brain/awr270
  76. Zhang XL, 2018, STEREOT FUNCT NEUROS, V96, P239, DOI 10.1159/000492056
  77. BOIVIE J, 1989, PAIN, V37, P173, DOI 10.1016/0304-3959(89)90128-0
  78. ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x
  79. Zorowitz Richard D, 2005, Top Stroke Rehabil, V12, P11, DOI 10.1310/EWCY-LJ68-LHE0-54AF
  80. Boivie J, 2003, EUR J PAIN, V7, P339, DOI 10.1016/S1090-3801(03)00046-6
  81. Bouhassira D, 2005, PAIN, V114, P160, DOI 10.1016/j.pain.2004.12.014
  82. Bouhassira D, 2005, PAIN, V114, P29, DOI 10.1016/j.pain.2004.12.010
  83. Bouhassira D, 2004, PAIN, V108, P248, DOI 10.1016/j.pain.2003.12.024
  84. Bouhassira D, 2021, PAIN, V162, P1038, DOI 10.1097/j.pain.0000000000002130
  85. BOWSHER D, 1995, POSTGRAD MED J, V71, P598, DOI 10.1136/pgmj.71.840.598
  86. Bowsher D, 1996, J NEUROL NEUROSUR PS, V61, P62, DOI 10.1136/jnnp.61.1.62
  87. Bowsher D, 1998, NEUROLOGY, V51, P1352, DOI 10.1212/WNL.51.5.1352
  88. Bowsher D, 2005, J PAIN, V6, P736, DOI 10.1016/j.jpain.2005.06.009
  89. Bowsher D, 2005, EUR NEUROL, V54, P14, DOI 10.1159/000086884
  90. Castro Martha Moreira Cavalcante, 2006, Rev. Bras. Anestesiol., V56, P470, DOI 10.1590/S0034-70942006000500005
  91. Choi-Kwon S, 2017, ACTA NEUROL SCAND, V135, P419, DOI 10.1111/ane.12617
  92. Ciaramitaro P, 2017, PAIN MED, V18, P2428, DOI 10.1093/pm/pnw360
  93. Cleeland C. S., 1994, Annals Academy of Medicine Singapore, V23, P129
  94. Cury RG, 2016, PAIN, V157, P2758, DOI 10.1097/j.pain.0000000000000697
  95. Cury RG, 2014, NEUROLOGY, V83, P1403, DOI 10.1212/WNL.0000000000000887
  96. dash.iwh.on.ca, DASH OUTCOME MEASURE
  97. De Andrade DC, 2017, ONCOLOGIST, V22, P1154, DOI 10.1634/theoncologist.2017-0235
  98. de Andrade DC, 2011, HEALTH QUAL LIFE OUT, V9, DOI 10.1186/1477-7525-9-107
  99. De Vloo P, 2017, PAIN, V158, P17, DOI 10.1097/j.pain.0000000000000722
  100. Defrin R, 2002, BRAIN, V125, P501, DOI 10.1093/brain/awf055
  101. Demant DT, 2015, PAIN, V156, P2234, DOI 10.1097/j.pain.0000000000000266
  102. Demant DT, 2014, PAIN, V155, P2263, DOI 10.1016/j.pain.2014.08.014
  103. Dongyang L, 2021, NEUROPHYSIOL CLIN, V51, P291, DOI 10.1016/j.neucli.2021.06.003
  104. Ducreux D, 2006, BRAIN, V129, P963, DOI 10.1093/brain/awl016
  105. Ferreira KA, 2011, SUPPORT CARE CANCER, V19, P505, DOI 10.1007/s00520-010-0844-7
  106. Finnerup NB, 2015, LANCET NEUROL, V14, P162, DOI 10.1016/S1474-4422(14)70251-0
  107. FISCHER AA, 1987, PAIN, V30, P115, DOI 10.1016/0304-3959(87)90089-3
  108. Fitzek S, 2001, ANN NEUROL, V49, P493
  109. Flor H, 2016, PAIN PHYSICIAN, V19, P507
  110. Freeman R, 2014, PAIN, V155, P367, DOI 10.1016/j.pain.2013.10.023
  111. Galhardoni GR, 2019, NEUROLOGY, V92, pE2165, DOI 10.1212/WNL.0000000000007396
  112. Garcia-Larrea L, 2012, NEUROPHYSIOL CLIN, V42, P299, DOI 10.1016/j.neucli.2012.06.001
  113. Garcia-Larrea L, 2013, PAIN, V154, pS29, DOI 10.1016/j.pain.2013.09.001
  114. Garcia-Larrea L, 2010, BRAIN, V133, P2528, DOI 10.1093/brain/awq220
  115. Giordano PCM., 2009, THESIS U CAMPINAS
  116. Greenspan JD, 2004, PAIN, V109, P357, DOI 10.1016/S0304-3959(04)00068-5
  117. Guimaraes, 2004, REV BRAS NEUROL, V40, P5
  118. Gummesson C., 2006, BMC Musculoskelet Disord, V7, P1
  119. Hasan M, 2014, NEUROMODULATION, V17, P731, DOI 10.1111/ner.12198
  120. Hatem SM, 2010, BRAIN, V133, P3409, DOI 10.1093/brain/awq244
  121. Helme RD, 2018, PAIN, V159, P1005, DOI 10.1097/j.pain.0000000000001149
  122. Hettiarachchi C, 2011, J REHABIL MED, V43, P197, DOI 10.2340/16501977-0648